BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for BriaCell Therapeutics Corp - Warrants (15/01/2031)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BriaCell Therapeutics Corp - Warrants (15/01/2031) 52 week high is $1.00 as of January 16, 2026.
What is the 52-week low for BriaCell Therapeutics Corp - Warrants (15/01/2031)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BriaCell Therapeutics Corp - Warrants (15/01/2031) 52 week low is $0.65 as of January 16, 2026.
What is BriaCell Therapeutics Corp - Warrants (15/01/2031) stock price today?
What is the 50-day moving average of BriaCell Therapeutics Corp - Warrants (15/01/2031)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BriaCell Therapeutics Corp - Warrants (15/01/2031) 50-day moving average is $0.865.